# Tolterodine

## Detrusitol 2mg

| TAH Drug Code      | [ODET](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODET)                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Overactive bladder, With symptoms of urinary frequency, urgency, or urge incontinence.                                                                                                                                                                                                                                                                       |
| Dosing             | Adult: Initial, 2 mg BID; may decreasing to 1 mg BID depending on tolerability and response. Children: Safety and efficacy in pediatric patients has not been established on label. Pediatric Dosing recommedion from micromedex: 4 to 12 years: 1 mg twice daily(study dosage). Or younger than 5 years: 0.1 mg/kg/day, divided into 2 doses(study dosage). |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Hypersensitivity to the drug, tolterodine, or its ingredients. Uncontrolled narrow-angle glaucoma. Urinary retention.                                                                                                                                                                                                                                        |
| Adverse Effects    | Common Gastrointestinal: Abdominal pain (3% to 5% ), Constipation (6% to 7% ), Xerostomia (23% to 35% ) Neurologic: Headache (immediate-release, 7%) Serious Immunologic: Anaphylaxis Other: Angioedema                                                                                                                                                      |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tolterodine-drug-information)                                                                                                                                                                                                                                                                                   |

## DETRUSITOL SR 4mg prolonged-release

| TAH Drug Code      | [ODET4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODET4)                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of overactive bladder with symptoms of urinary urgency, frequency,or urge incontinence.                                                                                                                                                                                                           |
| Dosing             | Adults: Immediate release tablet: 2 mg BID; the dose may be lowered to 1 mg BID based on individual response and tolerability. Extended release capsule: 4 mg QD; dose may be lowered to 2 mg QD based on individual response and tolerability.                                                             |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                    |
| Contraindications  | Urinary retention, uncontrolled narrow angle glaucoma, myasthenia gravis, severe ulcerative colitis, toxic megacolon.                                                                                                                                                                                       |
| Adverse Effects    | Dry mouth, dyspepsia, dry eyes, fatigue, constipation, abdominal pain, dizziness, headache, somnolence, flatulence, vomiting, paresthesia, nervousness, dry skin. Gastrointestinal: Constipation (6% to 7% ), Xerostomia (15% to 30% ) Neurologic: Headache [7% (immediate release); 6% (extended release)] |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tolterodine-drug-information)                                                                                                                                                                                                                                  |

